What is the recommended acetylcysteine dosage for acetaminophen (paracetamol) poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Acetylcysteine Dosing for Paracetamol Poisoning

Administer N-acetylcysteine (NAC) with a loading dose of 140 mg/kg orally (or 150 mg/kg IV), followed by maintenance doses of 70 mg/kg every 4 hours for 17 additional doses, totaling 72 hours of treatment for patients at risk of hepatotoxicity based on the Rumack-Matthew nomogram. 1

Dosing Regimen Details

Standard FDA-Approved Protocol (Oral)

  • Loading dose: 140 mg/kg orally
  • Maintenance doses: 70 mg/kg every 4 hours for 17 doses (total 18 doses over 72 hours)
  • Dilute 20% solution to 5% concentration with diet cola or soft drinks
  • If vomiting occurs within 1 hour, repeat that dose 1

Intravenous Alternative (Traditional 3-Bag Regimen)

  • Bag 1: 150 mg/kg over 15 minutes (or 1 hour to reduce adverse reactions)
  • Bag 2: 50 mg/kg over 4 hours
  • Bag 3: 100 mg/kg over 16 hours
  • Total: 300 mg/kg over 21 hours 2

Emerging Two-Bag Regimen

Recent evidence supports a simplified two-bag approach that reduces adverse reactions while maintaining efficacy:

  • Bag 1: 200 mg/kg over 4 hours
  • Bag 2: 100 mg/kg over 16 hours
  • Total: 300 mg/kg over 20 hours 3

This two-bag regimen has similar efficacy but significantly fewer adverse reactions compared to the three-bag protocol and is now recommended in updated Australian/New Zealand guidelines 3.

Critical Timing Considerations

Initiate NAC immediately if ≤24 hours have elapsed from ingestion—do not wait for acetaminophen levels. 1

Efficacy by Treatment Timing

The window for optimal outcomes is narrow:

  • <8 hours: No severe hepatotoxicity when treated 4
  • 8-10 hours: 6.1% hepatotoxicity rate 4
  • 10-16 hours: 29% hepatotoxicity rate 4
  • 16-24 hours: 62% hepatotoxicity rate 4

Treatment within 8-10 hours is the critical threshold for preventing mortality and severe hepatotoxicity 4.

Risk Stratification Using Rumack-Matthew Nomogram

When to Treat

Administer NAC to patients with acetaminophen levels in the "possible" or "probable" risk zones (above the treatment line at 4-24 hours post-ingestion). 4

The nomogram applies only to:

  • Single acute ingestion
  • Known time of ingestion
  • Presentation within 24 hours
  • Levels drawn 4-24 hours post-ingestion

When NOT to Treat

Do not administer NAC if the acetaminophen level is clearly below the treatment line (non-toxic range) AND the ingestion occurred ≥4 hours before the level was drawn. 4

Special Populations and Scenarios

High-Risk/Massive Overdoses

For patients with acetaminophen concentrations >300 mg/L (>1,985 μmol/L) at 4 hours—more than double the nomogram line:

  • Use increased NAC dosing 3
  • For ingestions ≥30 g or ≥500 mg/kg, administer higher doses 3
  • However, recent data show that prompt standard-dose NAC within 8 hours prevents hepatotoxicity even in high-risk cases, while high-dose NAC after 8 hours may paradoxically increase hepatotoxicity markers without improving liver failure rates 5

Patients >100 kg

Use actual body weight for dosing calculations—do not cap at 100 kg. 6

The FDA label suggests maximum weights of 100-110 kg, but clinical practice increasingly uses actual weight-based dosing. Hepatotoxicity rates are higher in this population (33%), but adverse events remain non-serious 6.

Modified-Release Formulations

  • All potentially toxic ingestions (≥10 g or ≥200 mg/kg, whichever is less) should receive full NAC course
  • For ≥30 g or ≥500 mg/kg, use increased NAC doses 3

Unknown Time of Ingestion or Late Presentation

If acetaminophen is detectable and time is unknown, or if >24 hours post-ingestion with hepatotoxicity, administer NAC. 4

Established Hepatotoxicity or Hepatic Failure

Administer NAC to all patients with hepatic failure or hepatotoxicity thought to be due to acetaminophen, regardless of timing or nomogram position. 4

Practical Implementation

Initial Management Steps

  1. Empty stomach via lavage or ipecac (if within appropriate timeframe)
  2. Avoid activated charcoal immediately before NAC (it adsorbs NAC and reduces effectiveness) 1
  3. Draw baseline labs: acetaminophen level, AST, ALT, bilirubin, PT/INR, creatinine, BUN, glucose, electrolytes
  4. Start NAC immediately—do not wait for levels if ≤24 hours post-ingestion 1

Monitoring

  • Repeat liver enzymes, coagulation studies, and renal function daily if levels are in toxic range 1
  • Monitor for NAC-related adverse reactions (more common with rapid initial infusion)

Common Pitfalls

  1. Waiting for acetaminophen levels before starting NAC: This delays critical early treatment. Start immediately if ≤24 hours from ingestion 1

  2. Using activated charcoal after NAC administration: This reduces NAC effectiveness. If charcoal is needed for co-ingestions, lavage before giving NAC 1

  3. Stopping NAC prematurely in unclear cases: When in doubt (unknown time, unreliable history, detectable acetaminophen), complete the full course 4

  4. Capping weight at 100 kg: Use actual body weight for dosing 6

  5. Applying the nomogram to non-acute ingestions: The nomogram is invalid for repeated supratherapeutic ingestions, extended-release formulations, or unknown timing 4, 3

Evolving Practice

While the FDA-approved 72-hour oral or 21-hour IV three-bag regimen remains standard in the United States 1, 7, the two-bag regimen (200 mg/kg over 4 hours, then 100 mg/kg over 16 hours) offers equivalent efficacy with fewer adverse reactions and is gaining international acceptance 3, 8. The simplified dosing also reduces medication errors 8, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.